3003 results found
This information booklet provides guidance on how the Targeted Calls for Research (TCR) peer review process works, what is involved, and the role and responsibilities of consumer and community representatives (CCRs) on peer review panels.
NHMRC recognises that the COVID-19 pandemic may be affecting research involving animals, including delays to existing research projects, or new research relating to the pandemic that proposes to use animals.
These FAQs address common eligibility queries received during the application process for the Investigator, Ideas, and Synergy Grant schemes.
The 2024 Evaluation Strategy Implementation Report outlines NHMRC's evaluation-related activities, challenges, and achievements during the 2023–24 financial year (the reporting period). For long-term initiatives that commenced within this reporting period but continued into the 2024–25 financial year, progress updates as of March 2025 are also included.
Additional guidance on what constitutes a Probity Event under the NHMRC Funding Agreement.
NHMRC Approval
MRFF – Preventive and Public Health Research Initiative - 2025 Incorporating Patient Data in Health Technology Assessment Decision Making Grant Opportunity
MRFF – Global Health Initiative – 2025 Mental Health and Climate Change Grant Opportunity
MRFF – Early to Mid-Career Researchers Initiative – 2025 Early to Mid-Career Researchers Grant Opportunity
The fourteenth meeting of the National Health and Medical Research Council’s (NHMRC) Dietary Guidelines Expert Committee (Expert Committee) was held in April 2025 by videoconference.
The fifteenth meeting of the National Health and Medical Research Council’s (NHMRC) Dietary Guidelines Expert Committee (Expert Committee) was held in June 2025 by videoconference.
Eligibility criteria for studies related to questions on older adults and protein-rich foods, and diet and sustainability.
In 2022, working with its Health Research Impact Committee, National Health and Medical Research Council (NHMRC) developed the NHMRC Research Impact Position Statement.
We are committed to improving the health of Aboriginal and Torres Strait Islander peoples.
The Ethical Guidelines for Cell, Tissue and Organ Donation and Transplantation in Australia provide a framework to support ethical practice and inform decision-making by all those involved in Australia’s donation and transplantation system.
The ability to make insulin was one of the great medical breakthroughs of the 20th Century. However, it quickly became clear to clinicians and researchers how complicated the human body's systems were for regulating and using blood sugar. In the absence of a deep understanding of these systems, providing insulin could have dangers.
Infants are vulnerable to health challenges because of the relatively immature state of their bodies, including their nervous, cardiovascular and respiratory systems. Moreover, an infant may appear completely healthy but still have an underlying vulnerability that can make it difficult for that infant to cope with certain kinds of environmental stress.
This handbook outlines the requirements and procedures for the certification of institutions under our National Certification Scheme of Institutional Processes Related to the Ethical Review of Multi-centre Research. The handbook is currently under review. Before commencing steps to apply for certification, please contact us at HREC.admin@nhmrc.gov.au for further advice.
Pharmaxis Ltd is an Australian pharmaceutical research company established in 1998. It listed on the Australian Securities Exchange (ASX) in 2003. The business focuses on new therapies to treat inflammation and fibrosis with a portfolio of products at various stages of development and approval. With origins in clinical research, this Australian-owned start up successfully competes in an international market.